Search filters

List of works by Mads Hald Andersen

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

scientific article

A Potential Role of Indoleamine 2,3-Dioxygenase-Specific T cells in Leishmania Vaccination ⬇️

scientific article published on July 8, 2011

A Promiscuous Survivin-Derived T-Cell Epitope Restricted to the HLA-A3 Super-Type Alleles

scientific article published on 19 April 2012

A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

scientific article published on 09 December 2021

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis

scientific article published on 7 December 2008

Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4 + T- Cells, Which Dampen CD8 + T-cell Antitumor Reactivity

scientific article (publication date: 16 July 2015)

Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling.

scientific article

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

scientific article

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells

scientific article published in December 2002

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

scientific article published on November 2012

Anti-cancer immunotherapy: breakthroughs and future strategies

scientific article published on 21 September 2018

Anti-regulatory T cells

scientific article published on 27 September 2016

Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

scientific article published on 06 November 2019

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses

scientific article published on July 2012

Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21.

scientific article published on 13 July 2016

B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment

scientific article published on 18 August 2019

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL).

scientific article published on 12 June 2014

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

scientific article published on December 2012

Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transfer

scientific article published on 24 March 2011

Butyrate and propionate inhibit antigen-specific CD8+ T cell activation by suppressing IL-12 production by antigen-presenting cells

scientific article

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment.

scientific article published on 30 September 2016

CD4 responses against IDO ⬇️

scientific article published on October 1, 2012

CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpressing p53.

scientific article published on 17 February 2009

Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

scientific article published on 02 July 2020

Cancer and autoimmunity.

scientific article published on 27 March 2017

Cancer immune therapy for lymphoid malignancies: recent advances

scientific article published on 13 July 2018

Cancer treatment: the combination of vaccination with other therapies

scientific article published on 20 February 2008

Cellular based cancer vaccines: type 1 polarization of dendritic cells.

scientific article published on January 2012

Characterization and comparison of 'standard' and 'young' tumour-infiltrating lymphocytes for adoptive cell therapy at a Danish translational research institution.

scientific article published in February 2012

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot

scientific article published on 26 April 2012

Characterization of T-cell responses against IκBα in cancer patients

scientific article published on November 2012

Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application

scientific article published on 18 June 2011

Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes

scientific article published on November 2004

Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".

scientific article published in November 2009

Comment on “Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer” ⬇️

scientific article published on 01 June 2013

Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy

scientific article published on 29 November 2012

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

scientific article published on 29 November 2005

Cytotoxic T cells

scientific article

Data from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Data from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 12 May 2023

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients

scientific article published on February 2013

Durable Clinical Responses and Long-Term Follow-Up of Stage III-IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study-A Brief Research Report

article

Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration

scientific article published on December 2003

Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patient.

scientific article

Establishing the pig as a large animal model for vaccine development against human cancer

scientific article

Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer

scientific article published on 08 January 2020

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

scientific article published on 06 August 2019

Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.

scientific article

FOXP3-specific immunity.

scientific article published on 12 September 2013

Frequent adaptive immune responses against arginase-1.

scientific article published on 26 December 2017

Functional capacity of Mcl-1-specific cytotoxic T-cells

scientific article published on 25 May 2006

Functional characterization of Foxp3-specific spontaneous immune responses.

scientific article published in July 2013

HLA-A2-restricted survivin-derived T-cell responses

scientific article published on 11 May 2011

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

scientific article published on 4 September 2006

Harnessing PD-L1-specific cytotoxic T cells for anti-leukemia immunotherapy to defeat mechanisms of immune escape mediated by the PD-1 pathway

scientific article published on 12 September 2013

Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens

scientific article published on 19 October 2020

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals.

scientific article

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

scientific article published on May 2009

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

scientific article

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

scientific article

Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients

scientific article published on August 2009

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes

scientific article

Identification of novel survivin-derived CTL epitopes

scientific article published in February 2004

Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.

scientific article published on 10 June 2015

Immune-suppressive properties of the tumor microenvironment

scientific article published on 11 May 2013

Immunogenicity of Bcl-2 in patients with cancer

scientific article

Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

scientific article

Immunogenicity of constitutively active V599EBRaf

scientific article

Immunoprofiles of colorectal cancer from Lynch syndrome

scientific article published on 26 September 2018

Immunoregulatory antigens-novel targets for cancer immunotherapy

scientific article published on 01 April 2018

Immunotherapy for metastatic colorectal cancer: present status and new options

scientific article published on 03 January 2012

In situ cytokine therapy: redistribution of clonally expanded T cells

scientific article published on 01 January 2001

Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

scientific article published on 21 September 2017

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

scientific article

Indoleamine 2,3-dioxygenase vaccination

scientific article published in January 2015

Induction of Bcl-xL-specific cytotoxic T lymphocytes in mice.

scientific article

Inflammation induced PD-L1-specific T cells

scientific article published on 13 September 2019

Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin.

scientific article

Keeping each other in check: A reciprocal relationship between cytokines and miRNA ⬇️

scientific article published on July 15, 2013

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase

scientific article published on 7 November 2013

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase

scientific article published on 11 November 2013

Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).

scientific article

Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

scientific article published on 5 September 2017

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

scientific article published on 02 July 2019

Melanoma inhibitor of apoptosis protein (ML-IAP) specific cytotoxic T lymphocytes cross-react with an epitope from the auto-antigen SS56.

scientific article published on 12 February 2009

Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion

scientific article

Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase

scientific article (publication date: 2012)

Neo-antigen specific memory T-cell responses in healthy individuals

scientific article published on 19 April 2019

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

scientific article published on 01 October 2018

Novel understanding of self-reactive T cells.

scientific article

Oncogenic cancer/testis antigens: prime candidates for immunotherapy.

scientific article published on June 2015

PD-L1 expression in B-cell lymphomas and virus-associated malignancies--letter.

scientific article

PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine.

scientific article published on July 2016

PD-L1-specific T cells.

scientific article published on 02 January 2016

Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment

scientific article published on 27 January 2022

Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

scientific article published on 23 December 2016

Peripheral memory T cells specific for Arginase-1

scientific article published on 10 May 2019

Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination ⬇️

scientific article published on March 21, 2011

Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.

scientific article

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes

scientific article published on 15 July 2015

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

scientific article published on 01 July 2019

Rapid Identification of the Tumor-Specific Reactive TIL Repertoire Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens

scientific article published in 2021

Regulators of apoptosis: suitable targets for immune therapy of cancer

scientific article

Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies.

scientific article published on 16 July 2015

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

scientific article published on 22 August 2008

Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

scientific article published in August 2016

Self-reactive T cells: suppressing the suppressors

scientific article published on 25 December 2013

Shift from systemic to site-specific memory by tumor-targeted IL-2.

scientific article published on May 2004

Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

scientific article published on 09 August 2017

Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

scientific article published on 23 July 2018

Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.

scientific article published on 2 October 2004

Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

article

Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2.

scientific article published on March 2011

Spontaneous immunity against Bcl-xL in cancer patients

scientific article

Spontaneous presence of FOXO3-specific T cells in cancer patients.

scientific article published on 14 November 2014

Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

scientific article published on 17 July 2019

Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

scientific article published on 17 April 2020

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 12 May 2023

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 2 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 12 May 2023

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 12 May 2023

Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 2 October 2023

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published on 12 May 2023

Supplementary Material 1 from Uncoupling CD4<sup>+</sup> TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients.

scientific article published on 6 November 2014

T-cell clonotypes in cancer

scientific article

T-cell dependent immunoselection.

scientific article published on October 2012

The Balance Players of the Adaptive Immune System.

scientific article published on 13 February 2018

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

scientific article published on 18 August 2016

The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

scientific article published on 20 January 2016

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms.

scientific article

The T-win® technology: immune-modulating vaccines

scientific article published on 02 July 2018

The V617F and exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

scientific article published on 02 August 2017

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens ⬇️

scientific article published on August 1, 2010

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy.

scientific article

The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G.

scientific article published on 30 November 2017

The effect of short-chain fatty acids on human monocyte-derived dendritic cells

scientific article published on 6 November 2015

The expression, function and targeting of haem oxygenase-1 in cancer.

scientific article published on May 2014

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells

scientific article

The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenase

scientific article published on 7 September 2009

The immunodominant HLA-A2-restricted MART-1 epitope is not presented on the surface of many melanoma cell lines

scientific article published on October 2008

The immunogenicity of the hTERT540-548 peptide in cancer

scientific article published on January 2008

The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy.

scientific article published in November 2017

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

scientific article (publication date: February 2004)

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

scientific article published on 01 June 2020

The role of dendritic cells in cancer

scientific article published on 16 September 2016

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase ⬇️

scientific article published on 03 March 2012

The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity

scientific article published on 18 July 2014

The targeting of immunosuppressive mechanisms in hematological malignancies

scientific article published on 18 March 2014

The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancer

scientific article published on 13 October 2014

The targeting of tumor-associated macrophages by vaccination

scientific article published on 24 April 2019

The universal character of the tumor-associated antigen survivin

scientific article published on October 2007

Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD4 T Cells That Recognize Survivin-Expressing Cells

scientific article published on 29 June 2016

Therapeutic cancer vaccines in combination with conventional therapy

scientific article published on 29 June 2010

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

scientific article published on October 2008

Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer

scientific article published on 30 January 2015

Tumor associated antigen specific T-cell populations identified in ex vivo expanded TIL cultures

scientific article published on 17 December 2011

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

scientific article published in May 2023

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

scientific article published in October 2010

[Cancer immune therapy for the treatment of haematological malignancies] ⬇️

scientific article published on 01 March 2019

[Therapeutic cancer vaccination for treatment of haematological cancers] ⬇️

scientific article published on 01 October 2019

mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma.

scientific article

Paulina is supported by:

About Paulina

Help